1. Home
  2. LUNG vs LSEA Comparison

LUNG vs LSEA Comparison

Compare LUNG & LSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • LSEA
  • Stock Information
  • Founded
  • LUNG 1995
  • LSEA 2013
  • Country
  • LUNG United States
  • LSEA United States
  • Employees
  • LUNG N/A
  • LSEA N/A
  • Industry
  • LUNG Industrial Specialties
  • LSEA Homebuilding
  • Sector
  • LUNG Health Care
  • LSEA Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • LSEA Nasdaq
  • Market Cap
  • LUNG 296.1M
  • LSEA 300.4M
  • IPO Year
  • LUNG 2020
  • LSEA N/A
  • Fundamental
  • Price
  • LUNG $7.10
  • LSEA $7.06
  • Analyst Decision
  • LUNG Strong Buy
  • LSEA Buy
  • Analyst Count
  • LUNG 7
  • LSEA 4
  • Target Price
  • LUNG $12.64
  • LSEA $13.75
  • AVG Volume (30 Days)
  • LUNG 483.0K
  • LSEA 340.5K
  • Earning Date
  • LUNG 04-30-2025
  • LSEA 04-30-2025
  • Dividend Yield
  • LUNG N/A
  • LSEA N/A
  • EPS Growth
  • LUNG N/A
  • LSEA N/A
  • EPS
  • LUNG N/A
  • LSEA 0.47
  • Revenue
  • LUNG $83,789,000.00
  • LSEA $1,550,337,000.00
  • Revenue This Year
  • LUNG $17.96
  • LSEA $4.04
  • Revenue Next Year
  • LUNG $18.35
  • LSEA $5.27
  • P/E Ratio
  • LUNG N/A
  • LSEA $15.64
  • Revenue Growth
  • LUNG 22.01
  • LSEA 28.13
  • 52 Week Low
  • LUNG $5.46
  • LSEA $6.54
  • 52 Week High
  • LUNG $10.01
  • LSEA $14.91
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 46.79
  • LSEA 44.92
  • Support Level
  • LUNG $7.07
  • LSEA $7.04
  • Resistance Level
  • LUNG $7.65
  • LSEA $7.56
  • Average True Range (ATR)
  • LUNG 0.67
  • LSEA 0.45
  • MACD
  • LUNG -0.19
  • LSEA -0.00
  • Stochastic Oscillator
  • LUNG 12.93
  • LSEA 38.54

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About LSEA Landsea Homes Corporation

Landsea Homes Corp is a homebuilding company. It designs and builds homes and sustainable master-planned communities in some of the nation's desirable markets. The company's segments include Arizona, California, Florida, Metro New York, and Texas. It derives a majority of revenue from home sales in Florida.

Share on Social Networks: